[HTML][HTML] Burden of illness in people with Alzheimer's disease: a systematic review of epidemiology, comorbidities and mortality

KL Lanctôt, JH Hahn-Pedersen, CS Eichinger… - The journal of …, 2024 - Elsevier
Background Alzheimer's disease (AD) is the most common neurodegenerative disease
worldwide, and an updated quantification of its impact on morbidity, disability, and mortality …

Predictors for survival in patients with Alzheimer's disease: a large comprehensive meta-analysis

X Zheng, S Wang, J Huang, C Li, H Shang - Translational Psychiatry, 2024 - nature.com
The prevalence of Alzheimer's disease (AD) is increasing as the population ages, and
patients with AD have a poor prognosis. However, knowledge on factors for predicting the …

Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype

L Vermunt, SAM Sikkes, A Van Den Hout… - Alzheimer's & …, 2019 - Elsevier
Introduction We estimated the age-specific duration of the preclinical, prodromal, and
dementia stages of Alzheimer's disease (AD) and the influence of sex, setting …

Highly superior autobiographical memory (HSAM): A systematic review

J Talbot, G Convertino, M De Marco, A Venneri… - Neuropsychology …, 2024 - Springer
Abstract Individuals possessing a Highly Superior Autobiographical Memory (HSAM)
demonstrate an exceptional ability to recall their own past, excelling most when dates from …

Survival time and differences between dementia with Lewy bodies and Alzheimer's disease following diagnosis: A meta-analysis of longitudinal studies

C Mueller, P Soysal, A Rongve, AT Isik… - Ageing research …, 2019 - Elsevier
Objective To synthesize the evidence across longitudinal studies comparing survival in
dementia with Lewy bodies (DLB) and Alzheimer's disease (AD). Methods We conducted a …

The effect of comorbidities on survival in persons with Alzheimer's disease: a matched cohort study

B Rajamaki, S Hartikainen, AM Tolppanen - BMC geriatrics, 2021 - Springer
Background Alzheimer's disease (AD) is one of the leading causes of death world-wide, but
little is known on the role of comorbidities on mortality among people with AD. We studied …

[HTML][HTML] Assessing cost-effectiveness of early intervention in Alzheimer's disease: An open-source modeling framework

C Green, R Handels, A Gustavsson, A Wimo… - Alzheimer's & …, 2019 - Elsevier
Introduction We develop a framework to model disease progression across Alzheimer's
disease (AD) and to assess the cost-effectiveness of future disease-modifying therapies …

Discovery of novel CSF biomarkers to predict progression in dementia using machine learning

D Gogishvili, EM Vromen, S Koppes-den Hertog… - Scientific Reports, 2023 - nature.com
Providing an accurate prognosis for individual dementia patients remains a challenge since
they greatly differ in rates of cognitive decline. In this study, we used machine learning …

Qß Virus-like particle-based vaccine induces robust immunity and protects against tauopathy

NM Maphis, J Peabody, E Crossey, S Jiang… - npj Vaccines, 2019 - nature.com
Tauopathies, including frontotemporal dementia (FTD) and Alzheimer's disease (AD) are
progressive neurodegenerative diseases clinically characterized by cognitive decline and …

[HTML][HTML] Association and pathways of birth in the stroke belt on old age dementia and stroke Mortality

M Top**, J Kim, J Fletcher - SSM-Population Health, 2021 - Elsevier
This paper uses data from the Diet and Health Study (DHS) to examine associations
between being born in a “stroke belt” state and old age stroke and mortality outcomes …